Companies / Paulex Bio
Paulex Bio
Company
Paulex Bio is working on a cure for type 1 and type 2 diabetes through beta cell regeneration
Paulex Bio has 1 investor on file, among them Lifespan Vision Ventures. Its site was last checked 6 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
In the news
1 headline naming Paulex BioEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
More from Lifespan Vision Ventures
23 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Lifespan Vision Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Paulex Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Lifespan Vision Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/paulexbio.com/investors
# also
GET /v1/companies/paulexbio.com
GET /v1/companies/paulexbio.com/news